Back to Search
LANCE DWORKIN, MD
MD
Nephrology Physician
NPI: 1053358770Individual
Specialties, Licenses & Credentials
Nephrology PhysicianPrimary
Internal Medicine — Nephrology
Code: 207RN0300X
MD08362(RI)35.129491(OH)
Research & Publications (20)
The utility of 6-month protocol renal biopsy under modern immunosuppression.
PMID 19049705·Clin Nephrol·2008
4-observational
Glycogen synthase kinase 3beta: a novel marker and modulator of inflammatory injury in chronic renal allograft disease.
PMID 18786229·Am J Transplant·2008
8-other
Candesartan suppresses chronic renal inflammation by a novel antioxidant action independent of AT1R blockade.
PMID 18650791·Kidney Int·2008
7-preclinical
IgA nephropathy: markers of progression and clues to pathogenesis.
PMID 18516058·Kidney Int·2008
8-other
Efficacy and safety of renal tubule cell therapy for acute renal failure.
PMID 18272842·J Am Soc Nephrol·2008
3-trial
Hepatocyte growth factor suppresses proinflammatory NFkappaB activation through GSK3beta inactivation in renal tubular epithelial cells.
PMID 18201972·J Biol Chem·2008
8-other
Long-term, high-dosage candesartan suppresses inflammation and injury in chronic kidney disease: nonhemodynamic renal protection.
PMID 17287430·J Am Soc Nephrol·2007
7-preclinical
Is renal artery stenting the correct treatment of renal artery stenosis? Case against angioplasty and stenting of atherosclerotic renal artery stenosis.
PMID 17228013·Circulation·2007
6-review
Anti-inflammatory effect of hepatocyte growth factor in chronic kidney disease: targeting the inflamed vascular endothelium.
PMID 16885407·J Am Soc Nephrol·2006
7-preclinical
Controversial treatment of atherosclerotic renal vascular disease: the cardiovascular outcomes in renal atherosclerotic lesions trial.
PMID 16864748·Hypertension·2006
6-review
Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial.
PMID 16824832·Am Heart J·2006
8-other
Excess risk of renal allograft loss and early mortality among elderly recipients is associated with poor exercise capacity.
PMID 16792134·Clin Nephrol·2006
4-observational
Hepatocyte growth factor suppresses acute renal inflammation by inhibition of endothelial E-selectin.
PMID 16501492·Kidney Int·2006
8-other
The Cardiovascular Outcomes with Renal Atherosclerotic Lesions (CORAL) study: rationale and methods.
PMID 16221898·J Vasc Interv Radiol·2005
8-other
Activation of PI3K-Akt-GSK3beta pathway mediates hepatocyte growth factor inhibition of RANTES expression in renal tubular epithelial cells.
PMID 15781227·Biochem Biophys Res Commun·2005
8-other
Hepatocyte growth factor induces an endothelin-mediated decline in glomerular filtration rate.
PMID 15583218·Am J Physiol Renal Physiol·2005
7-preclinical
Hepatocyte growth factor ameliorates renal interstitial inflammation in rat remnant kidney by modulating tubular expression of macrophage chemoattractant protein-1 and RANTES.
PMID 15504940·J Am Soc Nephrol·2004
7-preclinical
Incidence of hyperkalemia in high risk patients during treatment with an angiotensin converting enzyme inhibitor (Lisinopril) versus an angiotensin II receptor blocker (Losartan).
PMID 15253477·S D J Med·2004
3-trial
Hepatocyte growth factor ameliorates progression of interstitial fibrosis in rats with established renal injury.
PMID 14717911·Kidney Int·2004
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 3 locations total
- Address
- 1125 Hospital Dr
Toledo, OH 43614 - Phone
- (419) 383-4382
Quick Facts
- NPI
- 1053358770
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 3
- Publications
- 20
Are you this provider?
Claim Your Profile